Using QALYs as an Outcome for Assessing Global Prediction Accuracy in Diabetes Simulation Models.
使用 QALYs 作為評估糖尿病模擬模型全球預測準確性的結果指標。
Med Decis Making 2024-10-30
The challenges and pitfalls of incorporating evidence from cardiovascular outcomes trials in health economic modelling of type 2 diabetes.
將此醫學文章的標題翻譯為繁體中文：「將心血管結果試驗證據納入第2型糖尿病健康經濟建模的挑戰與陷阱」。
Diabetes Obes Metab 2023-03-16
Model-based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease.
在患有2型糖尿病和確診心血管疾病的人群中實施 empagliflozin 的健康效益和預算影響的基於模型的預測。
Diabetes Obes Metab 2023-04-19
Assessment of Glucose Lowering Medications' Effectiveness for Cardiovascular Clinical Risk Management of Real-World Patients with Type 2 Diabetes: Targeted Maximum Likelihood Estimation under Model Misspecification and Missing Outcomes.
評估葡萄糖降低藥物對第二型糖尿病實際世界患者心血管臨床風險管理的有效性：在模型錯誤和遺漏結果下的目標最大概似估計。
Int J Environ Res Public Health 2023-09-18
Joint longitudinal and time-to-event modelling compared with standard Cox modelling in patients with type 2 diabetes with and without established cardiovascular disease: An analysis of the EXSCEL trial.
在具有和沒有確診心血管疾病的2型糖尿病患者中，聯合長期和事件時間模型與標準 Cox 模型的比較：EXSCEL 試驗分析。
Diabetes Obes Metab 2023-04-06
Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data.
GLP-1受體激動劑與長效胰島素對於具有或不具有心血管疾病或慢性腎臟疾病的2型糖尿病患者的價值：使用真實世界數據進行基於模型的成本效益分析。
Diabetes Res Clin Pract 2023-04-10
A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetes.
結合臨床和行政資料庫評估人口規模並估計新授權藥物所需資源的方法：以第二型糖尿病中糖化血紅蛋白為例。
Pharmacoepidemiol Drug Saf 2023-10-10
Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide.
將 IQVIA 核心糖尿病模型校準至一周一次的 semaglutide 在 SUSTAIN 6 心血管結果試驗中的中風結果。
J Med Econ 2023-11-06
An ensemble-based machine learning model for predicting type 2 diabetes and its effect on bone health.
一個基於集成的機器學習模型，用於預測第二型糖尿病及其對骨骼健康的影響。
BMC Med Inform Decis Mak 2024-05-29
Updating and calibrating the Real-World Progression In Diabetes (RAPIDS) model in a non-Veterans Affairs population.
在非退伍軍人事務部族群中更新和校準糖尿病現實世界進展模型 (RAPIDS)。
Diabetes Obes Metab 2024-09-03